What is Afton Scientific?
Afton Scientific operates as a premier US-based pharmaceutical contract development and manufacturing organization (CDMO). With a specialized focus on the sterile filling of small-volume injectable drugs, the company leverages over three decades of industry expertise to support both clinical trials and small-batch commercial production. By prioritizing regulatory compliance and operational agility, Afton Scientific has established itself as a vital partner for pharmaceutical developers requiring precision and rapid scheduling. Their service portfolio, which encompasses comprehensive contract manufacturing and laboratory services, is designed to navigate the complexities of modern drug development while maintaining rigorous quality standards.
How much funding has Afton Scientific raised?
Afton Scientific has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Afton Scientific
PPP
Public-Private Partnership
What's next for Afton Scientific?
With this late-stage capital injection, Afton Scientific is well-positioned to accelerate its strategic growth initiatives. The company is expected to focus on expanding its manufacturing capacity and enhancing its technological infrastructure to better serve the evolving needs of the biopharmaceutical sector. By optimizing its sterile filling capabilities and deepening its commitment to client-centric service models, Afton aims to capture a larger share of the contract manufacturing market. Future developments will likely center on scaling production throughput and strengthening its regulatory footprint, ensuring the firm remains at the forefront of pharmaceutical innovation and supply chain reliability.
See full Afton Scientific company page
